MiMedx Group (MDXG) Launches CHORIOFIX Placental Allograft for Complex, Tunneling Wounds

MiMedx Group Inc. (NASDAQ:MDXG) is one of the best biotech penny stocks to buy in 2026. On March 23, MiMedx officially announced the commercial launch of CHORIOFIX, the latest addition to its portfolio of advanced placental allografts. This organically developed product is a lyophilized human placental allograft designed to serve as a protective barrier for both acute and chronic wounds. It is specifically engineered to address complex clinical needs, such as large deficits and deep, tunneling wounds, which are historically difficult to treat effectively.

The allograft features a unique triple-layer construction, consisting of two chorion layers with an intact intermediate layer. This configuration makes CHORIOFIX the thickest product in the MiMedx portfolio to date, significantly enhancing its handling characteristics during positioning and suturing. Furthermore, its uniform, dual-sided design eliminates the need for specific orientation during application, providing a more streamlined experience for surgical and clinical staff.

MiMedx Group (MDXG) Launches CHORIOFIX Placental Allograft for Complex, Tunneling Wounds

In line with its focus on evidence-based outcomes, MiMedx Group Inc. (NASDAQ:MDXG) has integrated CHORIOFIX into its CAMPAIGN trial. This prospective randomized controlled trial is designed to evaluate the clinical performance of CHORIOFIX and EPIEFFECT against the standard of care in treating non-healing diabetic foot ulcers.

MiMedx Group Inc. (NASDAQ:MDXG) develops and sells placental tissue allografts to several sectors of the healthcare industry. It is involved in the processing of human placental tissues, the membrane, the umbilical cord, and the placental disc. It offers a range of wound care products, including Regentkit wound gel, Epicord, Epixpress, Choriofix, and more.

While we acknowledge the risk and potential of MDXG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MDXG and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.